Hidrasec Junior

Hidrasec Junior is an oral medication that contains the active ingredient racecadotril. It is marketed in the European Union as an enkephalinase inhibitor and is formulated for pediatric use. The product is intended to manage acute watery diarrhea in children, offering a non‑opioid approach to reduce intestinal fluid loss and improve hydration status.

Hidrasec Junior is indicated for the short‑term treatment of acute watery diarrhea in children. It helps to control stool output and supports rehydration efforts.

- Management of acute watery diarrhea in pediatric patients - Adjunct to oral rehydration therapy - Reducing stool frequency and volume - Supporting fluid and electrolyte balance during diarrheal episodes - May be used in community or clinical settings where rapid symptom control is needed

Adverse reactions to Hidrasec Junior are generally mild, but monitoring is advised.

Common: - Mild abdominal discomfort - Nausea - Transient headache - Slight increase in constipation risk - Mild skin rash or itching

Serious: - Severe allergic reaction (anaphylaxis) - Persistent vomiting - Marked abdominal pain or bloating - Signs of hepatic dysfunction (rare) - Severe rash with blistering (Stevens‑Johnson syndrome)

Before using Hidrasec Junior, consider the following safety points.

- Verify the child's age and weight to ensure appropriate use - Assess for known hypersensitivity to racecadotril or excipients - Use caution in patients with pre‑existing liver disease - Monitor for signs of dehydration despite treatment - Avoid use if the diarrhea is caused by bacterial infection requiring antibiotics - Consult a healthcare professional if diarrhea persists beyond 48‑72 hours - Keep the medication out of reach of children to prevent accidental ingestion

Potential drug interactions should be reviewed prior to initiating therapy.

Avoid: - Concomitant use with potent opioid agonists that may mask gastrointestinal effects - Combination with medications that significantly alter gut motility (e.g., prokinetics)

Use with caution: - Antacids that may affect absorption of oral formulations - Drugs metabolized by hepatic enzymes that could be inhibited by racecadotril metabolites - Concurrent use of other antidiarrheal agents (e.g., loperamide) to avoid excessive reduction of gut motility - Herbal supplements affecting gastrointestinal function